Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling.

Tan MJ, White EA, Sowa ME, Harper JW, Aster JC, Howley PM.

Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):E1473-80. doi: 10.1073/pnas.1205991109. Epub 2012 Apr 30.

2.

Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling.

Brimer N, Lyons C, Wallberg AE, Vande Pol SB.

Oncogene. 2012 Oct 25;31(43):4639-46. doi: 10.1038/onc.2011.589. Epub 2012 Jan 16.

3.

The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation.

Meyers JM, Spangle JM, Munger K.

J Virol. 2013 Apr;87(8):4762-7. doi: 10.1128/JVI.02527-12. Epub 2013 Jan 30.

4.

Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes.

White EA, Walther J, Javanbakht H, Howley PM.

J Virol. 2014 Aug;88(15):8201-12. doi: 10.1128/JVI.01197-14. Epub 2014 May 21.

5.

Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation.

Meyers JM, Uberoi A, Grace M, Lambert PF, Munger K.

PLoS Pathog. 2017 Jan 20;13(1):e1006171. doi: 10.1371/journal.ppat.1006171. eCollection 2017 Jan.

6.

Interactions between E6AP and E6 proteins from alpha and beta HPV types.

Thomas M, Tomaić V, Pim D, Myers MP, Tommasino M, Banks L.

Virology. 2013 Jan 20;435(2):357-62. doi: 10.1016/j.virol.2012.11.004. Epub 2012 Dec 1.

7.

Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo.

Oyama T, Harigaya K, Sasaki N, Okamura Y, Kokubo H, Saga Y, Hozumi K, Suganami A, Tamura Y, Nagase T, Koga H, Nishimura M, Sakamoto R, Sato M, Yoshida N, Kitagawa M.

Development. 2011 Dec;138(23):5235-46. doi: 10.1242/dev.062802.

8.

HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage.

Wallace NA, Robinson K, Howie HL, Galloway DA.

PLoS Pathog. 2012;8(7):e1002807. doi: 10.1371/journal.ppat.1002807. Epub 2012 Jul 12.

9.

E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation.

Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA.

J Virol. 2008 Nov;82(21):10408-17. doi: 10.1128/JVI.00902-08. Epub 2008 Aug 20.

10.

Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.

Connolly K, Manders P, Earls P, Epstein RJ.

Cancer Treat Rev. 2014 Mar;40(2):205-14. doi: 10.1016/j.ctrv.2013.08.005. Epub 2013 Aug 22. Review.

PMID:
24051018
11.

E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein.

Handa K, Yugawa T, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T.

J Virol. 2007 Feb;81(3):1379-89. Epub 2006 Nov 22.

12.

The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes.

Bedard KM, Underbrink MP, Howie HL, Galloway DA.

J Virol. 2008 Apr;82(8):3894-902. doi: 10.1128/JVI.01818-07. Epub 2008 Feb 6.

13.

Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness.

Brimer N, Drews CM, Vande Pol SB.

PLoS Pathog. 2017 Dec 27;13(12):e1006781. doi: 10.1371/journal.ppat.1006781. eCollection 2017 Dec.

14.
15.
16.

Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.

Cornet I, Bouvard V, Campo MS, Thomas M, Banks L, Gissmann L, Lamartine J, Sylla BS, Accardi R, Tommasino M.

J Virol. 2012 Feb;86(4):2366-70. doi: 10.1128/JVI.06579-11. Epub 2011 Dec 14.

17.

Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association.

Howie HL, Koop JI, Weese J, Robinson K, Wipf G, Kim L, Galloway DA.

PLoS Pathog. 2011 Aug;7(8):e1002211. doi: 10.1371/journal.ppat.1002211. Epub 2011 Aug 25.

18.

Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.

Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, Laimins LA.

EMBO J. 1992 Aug;11(8):3045-52. Erratum in: EMBO J 1992 Nov;11(11):4248.

19.

Beta human papillomavirus E6 expression inhibits stabilization of p53 and increases tolerance of genomic instability.

Wallace NA, Robinson K, Galloway DA.

J Virol. 2014 Jun;88(11):6112-27. doi: 10.1128/JVI.03808-13. Epub 2014 Mar 19.

20.

Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis.

Muench P, Probst S, Schuetz J, Leiprecht N, Busch M, Wesselborg S, Stubenrauch F, Iftner T.

Cancer Res. 2010 Sep 1;70(17):6913-24. doi: 10.1158/0008-5472.CAN-10-1307. Epub 2010 Jul 27.

Supplemental Content

Support Center